Læknaneminn - 01.10.1988, Blaðsíða 13

og Cleary.J.B.: Breast Cancer. Diagnosis and Treatment.
(McGray-Hill, NewYork); bls. 119-125.
(15) HurlmannJ. og Saraga.P. (1985) - “Mononuclear cells
infiltrating Human Mammary Carcinomas: Immuno-
histochemical Analysis with Monoclonal Antibodies”.
Int J.Cancer,35 ;bls. 753-762.
(16) Elston,C.W„ Gresham,G.A„ Rad,G.S„ Zebro,T„
HaybittleJ.L., Houghton.J. og Keamey.G. (1982) - “The
Cancer Research Campaign (King s Cambridge). Trial for
early Breast Cancer: Colinico-pathological aspects”.
Br.J.Cancer,45 ; bls. 668.
(17) HamlinJ.M.E. (1968) - “Possible Host resistance in
Carcinoma of the Breast: A Histological Study”.
Br.J.Cancer,22; bls. 383-400.
(18) Benjamini,E„ Rennick.D.M.og Sell,S. (1984)-”Tumor
Immunology”. I Stites,D.P„ Stobe,J.D„ Fudenberg.H.H. og
WellsJ.V.: Basic and Clinical Immunology. (LANGE
Medical Publications, Califomia); bls. 223-240.
(19) Hakim,A.A. (1988) - “Peripheral Blood Lymphcytes,
from Patients with Cancer lack interleukin-2 Receptors”.
Cancer,61 ; bls. 689-701.
(20) Sutcieffe.S.B. og Gottlieb.A.A. (1986) - “Immune
Reactivity and Prognosis”. I Stoll.B.A.: Breast Cancer.
Treatment and Prognosis. (Blackwell, Oxford); bls 212-224.
(21) Taylor.G. og Odili,J.L. (1970)-"TumorSpecificT-like
Antigen of Human Breast Carcinoma”. Br.J.Cancer,24; bls.
447-452.
(22) Wood.G.W. og Gollahon,K.A. (1977) - “Detection and
QuantitationofMacrophage Infiltration into primary Human
Tumors with the use of Cell-surface Markers”.
J.Natn.CancerInst.,59; bls. 1081.
(23) Rowe,D.J.og Beverley,P.C.L. (1984) -
”Characterisation of breast cancer infiltrates using
monoclonal antibodies to human leucocyte antigens”.
Br.J.Cancer,49; bls. 149-159.
(24) Bröcker,E„ Zwadio,G„ Holzmann,B„ Macher,E. og
Sorg.C. (1988) - “Inflammatory Celi Infiltrats in Human
Melanoma at different stage of Tumor Progression”. Int.J.
Cancer,41 ; bls. 562-566.
(25) McCluskey.D.R., Roy,A.D„ Abram.W.P. og
Martin,W.M.C. (1983)- “T lymphocyte subsets of peripheral
blood of patients with benign and malignant breast disease”.
Br.J.Cancer,47; bls. 307-308.
(26) Lwin.K.Y., Zuccarini,0„ SloaneJ.P. og Beverley,
P.C .J. (1985) - “An Immunohistological Study of Leukocyte
Localization in Benign and Malign Breast Tissue”.
Int.J.Cancer,36; bls. 433-437.
(27) DrifeJ.O., McClelland.D.B.L., Pryde,A„ Roberts,M.
og SmithJ.I. (1977) - “Immunoglobulin Synthesis in
the”Resting”Breast”. í McClelland,D.B.L.: Humoral
Defense Factors of the Gastrointestinal Tract. (Edinburgh);
bls. 145-155.
(28) Tötterman,T.H„ Hayry,P„ Saksela,E„ Timonen,T. og
Eklund,B. (1978) - “Cytological and functional analysis of
inflammatory infiltrates in human malignant tumors”.
Eur.J.Immunol.,8; bls. 872-875.
(29) Dube,V.E„ Kallio.P. og Hakim.A. (1988) -
“Suppression of lymphocyte function with breast carcinoma.
I-Activeglycopeptides”. Immunologicallnvestigations, 17;
bls. 19-24.
(30) Dvorak,H.F., Dickersin.R., Dvorak,A.M.,
Manseau,E.J. og Pyne,K. (1981) - “Human Breast
Carcinoma: Fibrin deposits and desmoplasia. Infilammatory
cell type and Distribution. Microvasculature and infarction”.
J.Natl.Cancer Inst.,2 ; bls. 335-339.
(31) GreinerJ.W., Tobi,M„ Fister.P.B., LangerJ.A. og
Pestka.S. (1985) - "Differential Responsiveness of
Mammary Carcinoma Cell Population Interferon
Enhancement of Tumor Antigen Expression”. Int.J.
Cancer,36; bls. 159-165.
Gleðileg jól og
farsœlt komandi ár
Akraness Apótek
Suðurgötu 32
Sími: 93-11966
LÆKNANEMINN %>88-41. árg.
11